Suppr超能文献

大鼠胚胎与肝细胞的共培养:一种致畸剂的体外检测

Co-culture of rat embryos and hepatocytes: in vitro detection of a proteratogen.

作者信息

Oglesby L A, Ebron M T, Beyer P E, Carver B D, Kavlock R J

出版信息

Teratog Carcinog Mutagen. 1986;6(2):129-38. doi: 10.1002/tcm.1770060206.

Abstract

The technique of whole embryo culture developed by New [Environ Health Perspect 18:105-110, 1976] provides a sensitive assay to evaluate the effects of a test chemical on embryo development independent of maternal influences. To detect proteratogens, this assay must be coupled with an exogenous metabolic activation system. We have developed methods for the co-cultivation of rat embryos with primary hepatocytes, which offers several advantages over subcellular fractions when providing metabolic activation for in vitro assays. In the present study, rat embryos removed from the dam on day 10 of pregnancy were co-cultivated in vitro with primary cultures of rat, rabbit, or hamster hepatocytes. Embryos co-cultivated with hepatocytes developed normally, as did embryos exposed to a test chemical, cyclophosphamide (CP) in the absence of hepatocytes. When embryos were co-cultivated with hepatocytes and exposed to CP, a dose-related embryotoxicity was observed, indicating metabolic activation of the proteratogen. Using hepatocytes isolated from rats pretreated in vivo with phenobarbital, we observed an increase in CP-induced malformations and embryotoxicity compared to those of embryos exposed to CP in the presence of uninduced hepatocytes. The teratogenic bioactivation of CP was inhibited in vitro by the addition of metyrapone. When similar numbers of hepatocytes were used for metabolic activation of CP the induced embryotoxicity was greater in the presence of rabbit and hamster hepatocytes than with rat hepatocytes. Development of procedures for the culture of rat embryos with hepatocytes from other species suggests the utility of this in vitro system for the investigation of species differences in sensitivity to chemical teratogens.

摘要

纽(《环境健康展望》18:105 - 110,1976年)开发的全胚胎培养技术提供了一种灵敏的检测方法,可独立于母体影响来评估受试化学物质对胚胎发育的影响。为了检测致畸原,该检测必须与外源性代谢活化系统相结合。我们已经开发出大鼠胚胎与原代肝细胞共培养的方法,在为体外检测提供代谢活化方面,该方法比亚细胞组分具有几个优势。在本研究中,妊娠第10天从母鼠体内取出的大鼠胚胎与大鼠、兔或仓鼠的原代肝细胞进行体外共培养。与肝细胞共培养的胚胎正常发育,未与肝细胞共培养而暴露于受试化学物质环磷酰胺(CP)的胚胎也是如此。当胚胎与肝细胞共培养并暴露于CP时,观察到剂量相关的胚胎毒性,表明致畸原发生了代谢活化。使用从体内用苯巴比妥预处理的大鼠分离的肝细胞,我们观察到与在未诱导的肝细胞存在下暴露于CP的胚胎相比,CP诱导的畸形和胚胎毒性增加。添加美替拉酮可在体外抑制CP的致畸生物活化。当使用相似数量的肝细胞进行CP的代谢活化时,在兔和仓鼠肝细胞存在下诱导的胚胎毒性比在大鼠肝细胞存在下更大。开发大鼠胚胎与其他物种肝细胞共培养的程序表明,这种体外系统可用于研究对化学致畸剂敏感性的物种差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验